It has also been suggested that HPSC mobilization would be improved by plerixafor combined with G-CSF and pegylated-G-CSF after chemotherapy in patients with advanced germ cell cancer [122] as well as in those with MM or lymphoma. The gene discussed is CSF3; the disease is lymphoma.